Systemic lupus erythematosus (SLE) is an autoimmune disease with protean manifestations
that predominantly affects young women. Certain ethnic groups are more vulnerable than …

Clinical heterogeneity, unpredictable course and flares are characteristics of systemic lupus
erythematosus (SLE). Although SLE is—by and large—a systemic disease, occasionally it …

Objective To update the 2012 EULAR/ERA–EDTA recommendations for the management of
lupus nephritis (LN). Methods Following the EULAR standardised operating procedures, a …

Systemic lupus erythematosus (SLE) is the prototypical systemic autoimmune disease with a
significant disease burden across the world among different ethnic, racial, and age groups …

Systemic lupus erythematosus (SLE) is characterized by immune system dysfunction and is
clinically heterogeneous, exhibiting renal, dermatological, neuropsychiatric, and …

Objective Alterations in the microbiota composition of the gastro-intestinal tract are
suspected to be involved in the etiopathogenesis of two closely related systemic …

Obtaining an updated view of the epidemiology, risk factors, and prognosis of systemic lupus
erythematosus (SLE) is pivotal to our understanding of the disease burden. Recent …

Objectives Diagnostic reasoning in systemic lupus erythematosus (SLE) is a complex
process reflecting the probability of disease at a given timepoint against competing …

Objectives Systemic lupus erythematosus (SLE) diagnosis and treatment remain empirical
and the molecular basis for its heterogeneity elusive. We explored the genomic basis for …

Objectives Classification criteria are biased towards classifying long-standing disease. We
compared the European League Against Rheumatism (EULAR)/American College of …